 Charles Robertson
Concepts (525)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 762 | 3.610 |
Why?
| | Gastrointestinal Microbiome | 31 | 2025 | 698 | 2.650 |
Why?
| | RNA, Ribosomal, 16S | 45 | 2024 | 549 | 1.670 |
Why?
| | Bacteria | 31 | 2023 | 854 | 1.560 |
Why?
| | Intestinal Mucosa | 11 | 2025 | 621 | 0.950 |
Why?
| | Otitis Media | 6 | 2025 | 165 | 0.950 |
Why?
| | Cystic Fibrosis | 12 | 2023 | 1103 | 0.890 |
Why?
| | Feces | 17 | 2025 | 481 | 0.810 |
Why?
| | Intestines | 9 | 2017 | 357 | 0.750 |
Why?
| | Metagenome | 10 | 2019 | 147 | 0.740 |
Why?
| | Nasopharynx | 5 | 2024 | 76 | 0.680 |
Why?
| | Rhinitis | 6 | 2020 | 158 | 0.660 |
Why?
| | Biodiversity | 11 | 2020 | 409 | 0.650 |
Why?
| | Water Microbiology | 8 | 2018 | 85 | 0.640 |
Why?
| | Sinusitis | 6 | 2020 | 221 | 0.620 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 80 | 0.560 |
Why?
| | Phylogeny | 13 | 2020 | 902 | 0.530 |
Why?
| | Colon | 4 | 2025 | 282 | 0.530 |
Why?
| | Archaea | 2 | 2008 | 80 | 0.520 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 147 | 0.520 |
Why?
| | Air Microbiology | 2 | 2015 | 47 | 0.510 |
Why?
| | Ileum | 4 | 2020 | 119 | 0.490 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 809 | 0.480 |
Why?
| | Breast Feeding | 6 | 2025 | 439 | 0.470 |
Why?
| | RNA, Bacterial | 8 | 2018 | 190 | 0.440 |
Why?
| | Database Management Systems | 1 | 2013 | 51 | 0.420 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.410 |
Why?
| | Computer Graphics | 1 | 2013 | 42 | 0.410 |
Why?
| | User-Computer Interface | 1 | 2013 | 159 | 0.390 |
Why?
| | Aerosols | 1 | 2013 | 176 | 0.380 |
Why?
| | Geologic Sediments | 2 | 2008 | 46 | 0.370 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 109 | 0.370 |
Why?
| | Trachea | 4 | 2023 | 237 | 0.370 |
Why?
| | Colitis | 3 | 2025 | 266 | 0.360 |
Why?
| | HIV Infections | 5 | 2025 | 2821 | 0.350 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 144 | 0.350 |
Why?
| | Inflammation | 11 | 2025 | 2835 | 0.330 |
Why?
| | Crohn Disease | 4 | 2020 | 244 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | Dysbiosis | 5 | 2023 | 181 | 0.320 |
Why?
| | Humans | 80 | 2025 | 136750 | 0.310 |
Why?
| | DNA, Bacterial | 8 | 2021 | 337 | 0.310 |
Why?
| | Lung | 7 | 2021 | 4061 | 0.310 |
Why?
| | Genes, rRNA | 5 | 2015 | 41 | 0.300 |
Why?
| | Software | 1 | 2013 | 665 | 0.290 |
Why?
| | Male | 53 | 2025 | 67305 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 279 | 0.280 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 176 | 0.280 |
Why?
| | Case-Control Studies | 15 | 2020 | 3540 | 0.280 |
Why?
| | Female | 54 | 2025 | 72785 | 0.280 |
Why?
| | Mice | 23 | 2025 | 17758 | 0.270 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 9 | 0.270 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2021 | 654 | 0.260 |
Why?
| | Animals | 32 | 2025 | 36836 | 0.260 |
Why?
| | Legionella | 2 | 2017 | 7 | 0.260 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 215 | 0.250 |
Why?
| | HIV-1 | 2 | 2024 | 862 | 0.250 |
Why?
| | Dietary Supplements | 3 | 2019 | 559 | 0.240 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 189 | 0.240 |
Why?
| | Drinking Water | 3 | 2017 | 83 | 0.240 |
Why?
| | Fatty Liver | 2 | 2021 | 243 | 0.240 |
Why?
| | Blueberry Plants | 1 | 2025 | 7 | 0.240 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2894 | 0.240 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 56 | 0.240 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.240 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 224 | 0.240 |
Why?
| | Environmental Microbiology | 1 | 2005 | 53 | 0.240 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 325 | 0.230 |
Why?
| | Ear, Middle | 5 | 2025 | 85 | 0.230 |
Why?
| | Drug Resistance | 2 | 2017 | 169 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 15 | 0.230 |
Why?
| | Pentanols | 1 | 2024 | 5 | 0.230 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 169 | 0.230 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 137 | 0.230 |
Why?
| | Lyases | 1 | 2024 | 12 | 0.220 |
Why?
| | Metagenomics | 3 | 2019 | 167 | 0.220 |
Why?
| | Bacteremia | 2 | 2018 | 211 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2017 | 535 | 0.220 |
Why?
| | Th17 Cells | 1 | 2025 | 109 | 0.220 |
Why?
| | Adult | 30 | 2025 | 37626 | 0.220 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 449 | 0.220 |
Why?
| | Ecosystem | 2 | 2007 | 594 | 0.220 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5750 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 75 | 0.210 |
Why?
| | Liver | 3 | 2020 | 1940 | 0.210 |
Why?
| | Butyrates | 1 | 2024 | 61 | 0.210 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3710 | 0.210 |
Why?
| | Sputum | 5 | 2020 | 311 | 0.210 |
Why?
| | Child | 22 | 2025 | 21816 | 0.210 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 393 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 115 | 0.210 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 556 | 0.210 |
Why?
| | Respiratory System | 2 | 2016 | 157 | 0.200 |
Why?
| | Diet, Western | 2 | 2022 | 81 | 0.200 |
Why?
| | Premature Birth | 3 | 2017 | 331 | 0.200 |
Why?
| | Milk, Human | 3 | 2023 | 158 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2025 | 229 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 576 | 0.200 |
Why?
| | Staphylococcus | 4 | 2017 | 76 | 0.190 |
Why?
| | Iron | 2 | 2016 | 312 | 0.190 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.190 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 352 | 0.190 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2025 | 257 | 0.190 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 200 | 0.190 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1796 | 0.190 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 195 | 0.190 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1167 | 0.190 |
Why?
| | Infant | 12 | 2025 | 9395 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 387 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 42 | 0.180 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 393 | 0.180 |
Why?
| | Transcriptome | 3 | 2021 | 969 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 195 | 0.180 |
Why?
| | Diet | 3 | 2025 | 1274 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.180 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 399 | 0.170 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.170 |
Why?
| | Oropharynx | 2 | 2024 | 46 | 0.170 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5419 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.170 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 53 | 0.170 |
Why?
| | Perilipin-2 | 2 | 2017 | 41 | 0.170 |
Why?
| | Groundwater | 1 | 2020 | 40 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.170 |
Why?
| | Hot Springs | 2 | 2012 | 7 | 0.170 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 261 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.160 |
Why?
| | Birth Weight | 2 | 2020 | 514 | 0.160 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.160 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.160 |
Why?
| | Biofilms | 3 | 2017 | 259 | 0.160 |
Why?
| | Inflammation Mediators | 2 | 2020 | 513 | 0.160 |
Why?
| | Adolescent | 18 | 2021 | 21380 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 382 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 139 | 0.160 |
Why?
| | Middle Aged | 21 | 2024 | 33225 | 0.160 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4281 | 0.160 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1059 | 0.150 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 43 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 176 | 0.150 |
Why?
| | Chronic Disease | 7 | 2022 | 1786 | 0.150 |
Why?
| | Burns | 1 | 2023 | 325 | 0.150 |
Why?
| | Diet, High-Fat | 2 | 2017 | 247 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Biomarkers | 6 | 2025 | 4145 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2412 | 0.150 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 9 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Body Mass Index | 4 | 2020 | 2373 | 0.150 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 15 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 128 | 0.150 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 257 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.150 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.150 |
Why?
| | Quinolones | 1 | 2020 | 137 | 0.140 |
Why?
| | Probiotics | 1 | 2018 | 53 | 0.140 |
Why?
| | Aminophenols | 1 | 2020 | 156 | 0.140 |
Why?
| | Asthma | 3 | 2017 | 2282 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.140 |
Why?
| | Immunity, Innate | 3 | 2019 | 825 | 0.140 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 10 | 0.140 |
Why?
| | Infant, Newborn | 8 | 2025 | 6031 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Clostridium Infections | 1 | 2018 | 71 | 0.130 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 452 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 614 | 0.130 |
Why?
| | Child, Preschool | 9 | 2025 | 10997 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 489 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.130 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.130 |
Why?
| | Respiration, Artificial | 3 | 2023 | 642 | 0.130 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 316 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 604 | 0.130 |
Why?
| | Pedigree | 3 | 2025 | 514 | 0.130 |
Why?
| | Lipid Metabolism | 2 | 2020 | 512 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 124 | 0.120 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 17 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 64 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 10 | 0.120 |
Why?
| | Young Adult | 11 | 2021 | 13126 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 77 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 58 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Mice, Knockout | 5 | 2025 | 3009 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 304 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Lactobacillus | 3 | 2022 | 29 | 0.120 |
Why?
| | Cytokines | 3 | 2025 | 2084 | 0.120 |
Why?
| | Base Sequence | 3 | 2015 | 2179 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 145 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 34 | 0.120 |
Why?
| | Nose | 1 | 2015 | 67 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 65 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 83 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Bronchi | 1 | 2016 | 260 | 0.120 |
Why?
| | Biota | 1 | 2015 | 34 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.110 |
Why?
| | Prospective Studies | 7 | 2022 | 7572 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 50 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 227 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 236 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 115 | 0.110 |
Why?
| | Rats | 6 | 2023 | 5639 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 612 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 605 | 0.110 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 62 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 142 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 44 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 33 | 0.110 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 49 | 0.110 |
Why?
| | Nasal Cavity | 1 | 2013 | 52 | 0.100 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 107 | 0.100 |
Why?
| | Age Factors | 2 | 2019 | 3286 | 0.100 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 87 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 791 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 894 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 985 | 0.100 |
Why?
| | Cities | 1 | 2013 | 132 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 24 | 0.100 |
Why?
| | Computational Biology | 2 | 2019 | 643 | 0.100 |
Why?
| | Aged | 11 | 2023 | 23800 | 0.100 |
Why?
| | Saliva | 1 | 2015 | 242 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 218 | 0.100 |
Why?
| | New York City | 1 | 2013 | 85 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 99 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1496 | 0.100 |
Why?
| | Iron, Dietary | 1 | 2013 | 22 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 590 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 119 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2019 | 1163 | 0.100 |
Why?
| | Prednisone | 1 | 2013 | 239 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 234 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 346 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 584 | 0.100 |
Why?
| | Infant Food | 1 | 2013 | 65 | 0.100 |
Why?
| | Seawater | 1 | 2012 | 30 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 234 | 0.100 |
Why?
| | Pregnancy | 6 | 2025 | 6727 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2014 | 250 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.100 |
Why?
| | Mexico | 2 | 2012 | 225 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 254 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 267 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 66 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 43 | 0.090 |
Why?
| | Islets of Langerhans | 2 | 2015 | 803 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 140 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 36 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 259 | 0.090 |
Why?
| | Autoimmunity | 2 | 2015 | 908 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1467 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1097 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 255 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 413 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 395 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 164 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3189 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 2982 | 0.080 |
Why?
| | Indoles | 1 | 2013 | 410 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 83 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1914 | 0.080 |
Why?
| | Cholesterol | 2 | 2022 | 410 | 0.080 |
Why?
| | Cohort Studies | 5 | 2019 | 5703 | 0.080 |
Why?
| | Pacific Ocean | 1 | 2008 | 7 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 351 | 0.080 |
Why?
| | RNA, Archaeal | 1 | 2008 | 16 | 0.080 |
Why?
| | DNA, Archaeal | 1 | 2008 | 17 | 0.080 |
Why?
| | Weight Loss | 1 | 2014 | 776 | 0.080 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 155 | 0.080 |
Why?
| | Firmicutes | 2 | 2021 | 19 | 0.070 |
Why?
| | Exome | 2 | 2020 | 230 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 140 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2518 | 0.070 |
Why?
| | Methane | 2 | 2020 | 49 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 763 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 68 | 0.070 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 10 | 0.070 |
Why?
| | Fatty Acids | 2 | 2022 | 442 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 668 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 61 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2025 | 1982 | 0.070 |
Why?
| | Freezing | 1 | 2007 | 90 | 0.060 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 975 | 0.060 |
Why?
| | Equipment Contamination | 2 | 2017 | 63 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1036 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 769 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 345 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 98 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 194 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2406 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 114 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1033 | 0.060 |
Why?
| | Hexanols | 1 | 2024 | 4 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 678 | 0.060 |
Why?
| | Fruit | 1 | 2025 | 139 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 152 | 0.060 |
Why?
| | Methylamines | 1 | 2024 | 34 | 0.060 |
Why?
| | Treatment Outcome | 5 | 2020 | 10747 | 0.060 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 200 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2605 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 123 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 902 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 50 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 812 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2018 | 2831 | 0.050 |
Why?
| | Geography | 2 | 2014 | 198 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7593 | 0.050 |
Why?
| | Choline | 1 | 2024 | 127 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1507 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 560 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 119 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4512 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 95 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2643 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 845 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1236 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 77 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 228 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2664 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 183 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 10 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1180 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 265 | 0.050 |
Why?
| | Water | 2 | 2018 | 457 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 683 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 198 | 0.050 |
Why?
| | Gastritis | 1 | 2022 | 108 | 0.050 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 56 | 0.050 |
Why?
| | Enteritis | 1 | 2022 | 103 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 446 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2829 | 0.040 |
Why?
| | Endoscopy | 2 | 2015 | 318 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 661 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 21 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2021 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 600 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 872 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 31 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 785 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 220 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 684 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 218 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 93 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1620 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 87 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 217 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2838 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 47 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 552 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 115 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 364 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 10 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 133 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 72 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 188 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 531 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 53 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 125 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 106 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 369 | 0.040 |
Why?
| | Risk Factors | 3 | 2017 | 10330 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.040 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 37 | 0.030 |
Why?
| | Prognosis | 2 | 2020 | 4012 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 14 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 97 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 42 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 68 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 105 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 163 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 455 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 480 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 66 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 200 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1269 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 89 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 804 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 619 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 78 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 64 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 180 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 326 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 152 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 15 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 729 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3556 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 659 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 798 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 130 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 189 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 1022 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 31 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 31 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 116 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 115 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 185 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 67 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 40 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 514 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 22 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 15 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 31 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 49 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 161 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 43 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 215 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 50 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1458 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 120 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 93 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 186 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 492 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 99 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 281 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2051 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 32 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 63 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 497 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 143 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 341 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 178 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1500 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2184 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 317 | 0.030 |
Why?
| | Connectome | 1 | 2014 | 85 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 92 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 409 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1693 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 544 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 42 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 362 | 0.020 |
Why?
| | Neural Pathways | 1 | 2014 | 295 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 344 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 363 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1863 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 566 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 316 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 48 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 305 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 390 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 58 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 97 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 61 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2819 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1314 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 84 | 0.020 |
Why?
| | Suction | 1 | 2011 | 34 | 0.020 |
Why?
| | Skin | 1 | 2016 | 751 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 56 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 142 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 343 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 496 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 594 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 237 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 985 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5105 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2181 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1094 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 521 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 391 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 344 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 518 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 194 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 766 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 464 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2751 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 304 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 599 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4192 | 0.020 |
Why?
| | Risk | 1 | 2011 | 908 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1124 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3947 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1772 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 807 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Mining | 1 | 2007 | 21 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1377 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1544 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 981 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 2181 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 674 | 0.010 |
Why?
| | United States | 1 | 2015 | 14682 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 15499 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|